{
    "2019-08-27": [
        [
            {
                "time": "",
                "original_text": "研发投入几乎比肩净利润，华大基因临开拓增量市场难题",
                "features": {
                    "keywords": [
                        "研发投入",
                        "净利润",
                        "华大基因",
                        "增量市场"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因上半年净利润1.98亿元 研发投入同比增长51.63%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "净利润",
                        "研发投入",
                        "同比增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因半年业绩稳健增长 研发投入大增51.63%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "业绩",
                        "研发投入",
                        "增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)半年度业绩增长稳定 研发投入增长51.63%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "业绩",
                        "研发投入",
                        "增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：拟为四家下属子公司提供不超4.1亿元担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "华大基因",
                        "子公司",
                        "担保",
                        "借贷"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：上半年净利1.98亿元 同比下降4.7% 盈利能力下降",
                "features": {
                    "keywords": [
                        "华大基因",
                        "净利",
                        "同比下降",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：上半年计提资产减值准备共计5889万元 资产异常",
                "features": {
                    "keywords": [
                        "华大基因",
                        "资产减值",
                        "计提",
                        "资产异常"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：拟6000万元参与广州一产业投资基金",
                "features": {
                    "keywords": [
                        "华大基因",
                        "投资基金",
                        "参与",
                        "广州"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：上半年净利润1.98亿元，同比下降4.70% 盈利能力下降",
                "features": {
                    "keywords": [
                        "华大基因",
                        "净利润",
                        "同比下降",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}